Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies.

Ceribelli, Angela; Isailovic, Natasa; De Santis, Maria; Gorlino, Carolina; Satoh, Minoru; Selmi, Carlo

Ceribelli, Angela; Isailovic, Natasa; De Santis, Maria; Gorlino, Carolina; Satoh, Minoru; Selmi, Carlo.

Afiliação

Ceribelli A; Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
Isailovic N; Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
De Santis M; Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
Gorlino C; Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
Satoh M; Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan.
Selmi C; Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.

J Transl Autoimmun ; 3: 100049, 2020.

Article em En | MEDLINE | ID: mdl-32743530